--------------------------------------------------------------------------------

 
 
EXHIBIT 10.42

FIRST AMENDMENT TO CREDIT AND SECURITY AGREEMENT

THIS FIRST AMENDMENT TO CREDIT AND SECURITY AGREEMENT (this "Amendment") is
entered into as of August 9, 2016 by and among Strata Skin Sciences, Inc.
(formerly Mela Sciences, Inc.), a Delaware corporation (the "Borrower"), MidCap
Financial Trust, a Delaware statutory trust, as agent ("Agent") and the lenders
signatory hereto (the "Lenders").

RECITALS

A. Borrower, Agent and the Lenders are parties to that certain Credit and
Security Agreement, dated as of December 30, 2015 (as amended hereby and as may
be further amended, restated, supplemented, revised, restated, replaced or
otherwise modified from time to time, the "Credit Agreement"; capitalized terms
used herein and not otherwise defined shall have the meanings assigned to such
terms in the Credit Agreement), pursuant to which the Lenders have made certain
financial accommodations available to Borrower;
B. Borrower has requested that the Agent and Lenders amend certain provisions of
the Credit Agreement, and subject to the terms and conditions hereof, the Agent
and the Lenders executing this Amendment are willing to do so.
NOW, THEREFORE, in consideration of the premises and the mutual covenants
hereinafter contained, and intending to be legally bound, the parties hereto
agree as follows:

A.  AMENDMENTS

Subject to the satisfaction of the conditions precedent set forth in Section B
below, the parties hereto agree that the Credit Agreement is amended as follows:
1.
The Financial Covenant Schedule is hereby replaced in its entirety with the
Financial Covenant Schedule attached to this Amendment as Exhibit A.

B.  CONDITIONS TO EFFECTIVENESS
Notwithstanding any other provision of this Amendment and without affecting in
any manner the rights of the Lenders hereunder, it is understood and agreed that
this Amendment shall not become effective, and Borrower shall have no rights
under this Amendment, until Agent shall have received:

1.
reimbursement or payment of its costs and expenses incurred in connection with
this Amendment (including reasonable fees, charges and disbursements of counsel
to Agent and the Lenders);

2.
duly executed signature pages to this Amendment from the Lenders, the Borrower
and Agent; and

3.
a duly executed amendment and restatement of the fee letter agreement, dated as
of the Closing Date, by and between Borrower and Agent, in form and substance
acceptable to Agent.

C.  REPRESENTATIONS

To induce the Lenders and Agent to enter into this Amendment, each Credit Party
hereby represents and warrants to the Lenders and Agent that:

1. The execution, delivery and performance by such Credit Party of this
Amendment do not (i) conflict with any of such Credit Party's organizational
documents; (ii) contravene, conflict with, constitute a default under or violate
any Law; (iii) contravene, conflict or violate any applicable order,

--------------------------------------------------------------------------------

writ, judgment, injunction, decree, determination or award of any Governmental
Authority by which such Credit Party or any of its property or assets may be
bound or affected; (iv) require any action by, filing, registration, or
qualification with, or Required Permit from, any Governmental Authority (except
such Required Permits which have already been obtained and are in full force and
effect); or (v) constitute a default under or conflict with any Material
Agreement.
2. This Amendment has been duly authorized, executed and delivered by each
Credit Party and constitutes a legal, valid and binding agreement enforceable in
accordance with its terms.  The execution, delivery and performance by each
Credit Party of this Amendment is within such Credit Party's powers.

3. After giving effect to this Amendment, the representations and warranties
contained in the Credit Agreement and the other Financing Documents are true and
correct in all material respects (but in all respects if such representation or
warranty is qualified by "material" or "Material Adverse Effect"), except to the
extent such representations and warranties expressly relate to an earlier date,
in which case such representations and warranties were true and correct in all
material respects (but in all respects if such representation or warranty is
qualified by "material" or "Material Adverse Effect") on and as of such earlier
date, and no Default or Event of Default has occurred and is continuing as of
the date hereof.

D.  OTHER AGREEMENTS

1. Continuing Effectiveness of Financing Documents.  As amended hereby, all
terms of the Credit Agreement and the other Financing Documents shall be and
remain in full force and effect and shall constitute the legal, valid, binding
and enforceable obligations of the Credit Parties party thereto.  To the extent
any terms and conditions in any of the other Financing Documents shall
contradict or be in conflict with any terms or conditions of the Credit
Agreement, after giving effect to this Amendment, such terms and conditions are
hereby deemed modified and amended accordingly to reflect the terms and
conditions of the Credit Agreement as modified and amended hereby. Upon the
effectiveness of this Amendment such terms and conditions are hereby deemed
modified and amended accordingly to reflect the terms and conditions of the
Credit Agreement as modified and amended hereby.  This Amendment shall
constitute a Financing Document for all purposes of the Credit Agreement.
2. Reaffirmation. Each of the Credit Parties as debtor, grantor, pledgor,
guarantor, assignor, or in other any other similar capacity in which such Credit
Party grants liens or security interests in its property or otherwise acts as
accommodation party or guarantor, as the case may be, hereby ratifies and
reaffirms all of its payment and performance obligations, contingent or
otherwise, under each of the Financing Documents to which it is a party (after
giving effect hereto).  Each Credit Party hereby acknowledges that, as of the
date hereof, the security interests and liens granted to Agent and the Lenders
under the Credit Agreement and the other Financing Documents are in full force
and effect, are properly perfected and are enforceable in accordance with the
terms of the Credit Agreement and the other Financing Documents.
3. No Waiver or Novation.  The execution, delivery and effectiveness of this
Amendment shall not, except as expressly provided herein, operate as a waiver of
any right, power or remedy of the Lenders under the Credit Agreement, nor
constitute a waiver of any provision of the Credit Agreement.  This Amendment is
not intended by the parties to be, and shall not be construed to be, a novation
of the Credit Agreement and the other Financing Documents or an accord and
satisfaction in regard thereto.
4. Governing Law.   This Amendment shall be governed by, and construed in
accordance with, the internal laws of the State of Maryland and all applicable
federal laws of the United States of America.
5. Costs and Expenses.  Borrower agrees to pay on demand all reasonable costs
and expenses of Agent and the Lenders in connection with the preparation,
execution and delivery of this Amendment, including, without limitation, the
reasonable fees and out-of-pocket expenses of outside counsel for Agent and the
Lenders with respect thereto.
- 2 -

--------------------------------------------------------------------------------

6. Counterparts.  This Amendment may be executed in any number of counterparts
and by different parties on separate counterparts, each of which, when executed
and delivered, is an original, and all taken together, constitute one
agreement.  Delivery of an executed signature page of this Amendment by
facsimile transmission or electronic transmission shall be as effective as
delivery of a manually executed counterpart hereof.
7. Binding Nature.  This Amendment binds and is for the benefit of the
successors and permitted assigns of each party hereto.  No third party
beneficiaries are intended in connection with this Amendment.
8. Integration.  This Amendment and the Financing Documents represent the entire
agreement about this subject matter and supersede prior negotiations or
agreements.  All prior agreements, understandings, representations, warranties,
and negotiations between the parties about the subject matter of this Amendment
and the Financing Documents merge into this Amendment and the Financing
Documents.
9. Release.  Each Credit Party hereby releases, acquits, and forever discharges
Agent and each of the Lenders, and each and every past and present subsidiary,
affiliate, stockholder, officer, director, agent, servant, employee,
representative, and attorney of Agent and the Lenders, from any and all claims,
causes of action, suits, debts, liens, obligations, liabilities, demands,
losses, costs and expenses (including reasonable attorneys' fees) of any kind,
character, or nature whatsoever, known or unknown, fixed or contingent, which
such Credit Party may have or claim to have now or which may hereafter arise out
of or connected with any act of commission or omission of Agent or the Lenders
existing or occurring prior to the date of this Amendment or any instrument
executed prior to the date of this Amendment including, without limitation, any
claims, liabilities or obligations arising with respect to the Credit Agreement
or the other of the Financing Documents, other than claims, liabilities or
obligations caused by Agent's or any Lender's own gross negligence or willful
misconduct.  The provisions of this paragraph shall be binding upon each Credit
Party and shall inure to the benefit of Agent, the Lenders, and their respective
heirs, executors, administrators, successors and assigns.
[Signature pages follow]

- 3 -

--------------------------------------------------------------------------------

IN WITNESS WHEREOF, this Amendment has been duly executed as of the date first
written above.

BORROWER:
STRATA SKIN SCIENCES, INC.
By:/s/ Christina L. Allgeier               (SEAL)
Name: Christina L. Allgeier
Title: CFO

--------------------------------------------------------------------------------

AGENT:
MIDCAP FINANCIAL TRUST

By: Apollo Capital Management, L.P.,
    its investment manager

By: Apollo Capital Management GP, LLC,
    its general partner

By: /s/ Maurice Amsellem                              (SEAL)
Name:  Maurice Amsellem
Title:    Authorized Signatory

--------------------------------------------------------------------------------

LENDERS:
MIDCAP FUNDING XIII TRUST

By: Apollo Capital Management, L.P.,
    its investment manager

By: Apollo Capital Management GP, LLC,
    its general partner

By: /s/ Maurice Amsellem                              (SEAL)
Name:  Maurice Amsellem
Title:    Authorized Signatory

--------------------------------------------------------------------------------

FLEXPOINT MCLS HOLDINGS LLC

By:   /s/ Daniel Edelman
Name: Daniel Edelman
Title:   Vice President

--------------------------------------------------------------------------------

EXHIBIT A
FINANCIAL COVENANT SCHEDULE
Borrower shall not Permit consolidated net revenue of Borrower and its
Subsidiaries determined on a consolidated basis in accordance with GAAP for the
twelve month period ending on the last day of each calendar month set forth
below to be less than the minimum amount set forth below for such period.

 
Minimum Net Revenue - Covenant Level
     
TTM Period Ending (to be reported to Agent within 30 days after such date)
Number of Months in Testing Period
Minimum Net Revenue for Such Period
31-Jul-16
7
15,031,000
31-Aug-16
8
17,331,000
30-Sep-16
9
20,781,000
31-Oct-16
10
22,926,000
30-Nov-16
11
25,499,000
31-Dec-16
12
29,359,000
31-Jan-17
12
29,595,000
28-Feb-17
12
29,878,000
31-Mar-17
12
30,302,000
30-Apr-17
12
30,458,000
31-May-17
12
30,645,000
30-Jun-17
12
30,925,000
31-Jul-17
12
31,258,000
31-Aug-17
12
31,592,000
30-Sep-17
12
31,925,000
31-Oct-17
12
32,258,000
30-Nov-17
12
32,592,000
31-Dec-17
12
32,925,000
31-Jan-18
12
33,258,000
28-Feb-18
12
33,592,000
31-Mar-18
12
33,925,000
30-Apr-18
12
34,258,000
31-May-18
12
34,592,000
30-Jun-18
12
34,925,000
31-Jul-18
12
35,258,000
31-Aug-18
12
35,592,000
30-Sep-18
12
35,925,000
31-Oct-18
12
36,258,000
30-Nov-18
12
36,592,000
31-December-18 and the last day of each month occurring thereafter
12
36,785,000

 
 
 

--------------------------------------------------------------------------------